Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of HBV-MPL Vaccine vs Engerix-B in Healthy Volunteers
NCT00696917Phase 3Completed
- Sponsor
- GSK
- Start
- Apr 1999
- Primary completion
- Feb 2000
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 7
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant AS04-adjuvanted in hepatitis B (HBV), sponsored by GSK. Started Apr 1999; status: completed.
02
Drugs
hepatitis b vaccine recombinant AS04-adjuvanted
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00696917.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00696917.